Last updated
Gamma phage, an example of virus particles (visualised by electron microscopy) Gamma phage.png
Gamma phage, an example of virus particles (visualised by electron microscopy)

Virology is the scientific study of biological viruses. It is a subfield of microbiology that focuses on their detection, structure, classification and evolution, their methods of infection and exploitation of host cells for reproduction, their interaction with host organism physiology and immunity, the diseases they cause, the techniques to isolate and culture them, and their use in research and therapy.


The identification of the causative agent of tobacco mosaic disease (TMV) as a novel pathogen by Martinus Beijerinck (1898) is now acknowledged as being the official beginning of the field of virology as a discipline distinct from bacteriology. He realized the source was neither a bacterial nor a fungal infection, but something completely different. Beijerinck used the word "virus" to describe the mysterious agent in his 'contagium vivum fluidum' ('contagious living fluid'). Rosalind Franklin proposed the full structure of the tobacco mosaic virus in 1955.

One main motivation for the study of viruses is because they cause many infectious diseases of plants and animals. [1] The study of the manner in which viruses cause disease is viral pathogenesis. The degree to which a virus causes disease is its virulence. [2] These fields of study are called plant virology, animal virology and human or medical virology. [3] One main motivation for the study of viruses is because they cause many infectious diseases of plants and animals. [1] The study of the manner in which viruses cause disease is viral pathogenesis. The degree to which a virus causes disease is its virulence. [2] These fields of study are called plant virology, animal virology and human or medical virology. [3]

Virology began when there were no methods for propagating or visualizing viruses or specific laboratory tests for viral infections. The methods for separating viral nucleic acids (RNA and DNA) and proteins, which are now the mainstay of virology, did not exist. Now there are many methods for observing the structure and functions of viruses and their component parts. Thousands of different viruses are now known about and virologists often specialize in either the viruses that infect plants, or bacteria and other microorganisms, or animals. Viruses that infect humans are now studied by medical virologists. Virology is a broad subject covering biology, health, animal welfare, agriculture and ecology.


Martinus Beijerinck in his laboratory in 1921 Martinus Willem Beijerinck in his laboratory.jpg
Martinus Beijerinck in his laboratory in 1921

Louis Pasteur was unable to find a causative agent for rabies and speculated about a pathogen too small to be detected by microscopes. [4] In 1884, the French microbiologist Charles Chamberland invented the Chamberland filter (or Pasteur-Chamberland filter) with pores small enough to remove all bacteria from a solution passed through it. [5] In 1892, the Russian biologist Dmitri Ivanovsky used this filter to study what is now known as the tobacco mosaic virus: crushed leaf extracts from infected tobacco plants remained infectious even after filtration to remove bacteria. Ivanovsky suggested the infection might be caused by a toxin produced by bacteria, but he did not pursue the idea. [6] At the time it was thought that all infectious agents could be retained by filters and grown on a nutrient medium—this was part of the germ theory of disease. [7]

In 1898, the Dutch microbiologist Martinus Beijerinck repeated the experiments and became convinced that the filtered solution contained a new form of infectious agent. [8] He observed that the agent multiplied only in cells that were dividing, but as his experiments did not show that it was made of particles, he called it a contagium vivum fluidum (soluble living germ) and reintroduced the word virus. Beijerinck maintained that viruses were liquid in nature, a theory later discredited by Wendell Stanley, who proved they were particulate. [6] In the same year, Friedrich Loeffler and Paul Frosch passed the first animal virus, aphthovirus (the agent of foot-and-mouth disease), through a similar filter. [9]

In the early 20th century, the English bacteriologist Frederick Twort discovered a group of viruses that infect bacteria, now called bacteriophages [10] (or commonly 'phages'), and the French-Canadian microbiologist Félix d'Herelle described viruses that, when added to bacteria on an agar plate, would produce areas of dead bacteria. He accurately diluted a suspension of these viruses and discovered that the highest dilutions (lowest virus concentrations), rather than killing all the bacteria, formed discrete areas of dead organisms. Counting these areas and multiplying by the dilution factor allowed him to calculate the number of viruses in the original suspension. [11] Phages were heralded as a potential treatment for diseases such as typhoid and cholera, but their promise was forgotten with the development of penicillin. The development of bacterial resistance to antibiotics has renewed interest in the therapeutic use of bacteriophages. [12]

By the end of the 19th century, viruses were defined in terms of their infectivity, their ability to pass filters, and their requirement for living hosts. Viruses had been grown only in plants and animals. In 1906 Ross Granville Harrison invented a method for growing tissue in lymph, and in 1913 E. Steinhardt, C. Israeli, and R.A. Lambert used this method to grow vaccinia virus in fragments of guinea pig corneal tissue. [13] In 1928, H. B. Maitland and M. C. Maitland grew vaccinia virus in suspensions of minced hens' kidneys. Their method was not widely adopted until the 1950s when poliovirus was grown on a large scale for vaccine production. [14]

Another breakthrough came in 1931 when the American pathologist Ernest William Goodpasture and Alice Miles Woodruff grew influenza and several other viruses in fertilised chicken eggs. [15] In 1949, John Franklin Enders, Thomas Weller, and Frederick Robbins grew poliovirus in cultured cells from aborted human embryonic tissue, [16] the first virus to be grown without using solid animal tissue or eggs. This work enabled Hilary Koprowski, and then Jonas Salk, to make an effective polio vaccine. [17]

The first images of viruses were obtained upon the invention of electron microscopy in 1931 by the German engineers Ernst Ruska and Max Knoll. [18] In 1935, American biochemist and virologist Wendell Meredith Stanley examined the tobacco mosaic virus and found it was mostly made of protein. [19] A short time later, this virus was separated into protein and RNA parts. [20] The tobacco mosaic virus was the first to be crystallised and its structure could, therefore, be elucidated in detail. The first X-ray diffraction pictures of the crystallised virus were obtained by Bernal and Fankuchen in 1941. Based on her X-ray crystallographic pictures, Rosalind Franklin discovered the full structure of the virus in 1955. [21] In the same year, Heinz Fraenkel-Conrat and Robley Williams showed that purified tobacco mosaic virus RNA and its protein coat can assemble by themselves to form functional viruses, suggesting that this simple mechanism was probably the means through which viruses were created within their host cells. [22]

The second half of the 20th century was the golden age of virus discovery, and most of the documented species of animal, plant, and bacterial viruses were discovered during these years. [23] In 1957 equine arterivirus and the cause of bovine virus diarrhoea (a pestivirus) were discovered. In 1963 the hepatitis B virus was discovered by Baruch Blumberg, [24] and in 1965 Howard Temin described the first retrovirus. Reverse transcriptase, the enzyme that retroviruses use to make DNA copies of their RNA, was first described in 1970 by Temin and David Baltimore independently. [25] In 1983 Luc Montagnier's team at the Pasteur Institute in France, first isolated the retrovirus now called HIV. [26] In 1989 Michael Houghton's team at Chiron Corporation discovered hepatitis C. [27] [28]

Detecting viruses

An electron microscope Jeol Transmission and scanning EM.jpg
An electron microscope

There are several approaches to detecting viruses and these include the detection of virus particles (virions) or their antigens or nucleic acids and infectivity assays.

Electron microscopy

Electron micrographs of viruses. A, rotavirus; B, adenovirus; C, norovirus; and D, astrovirus. Gastroenteritis viruses.jpg
Electron micrographs of viruses. A, rotavirus; B, adenovirus; C, norovirus; and D, astrovirus.

Viruses were seen for the first time in the 1930s when electron microscopes were invented. These microscopes use beams of electrons instead of light, which have a much shorter wavelength and can detect objects that cannot be seen using light microscopes. The highest magnification obtainable by electron microscopes is up to 10,000,000 times [29] whereas for light microscopes it is around 1,500 times. [30]

Virologists often use negative staining to help visualise viruses. In this procedure, the viruses are suspended in a solution of metal salts such as uranium acetate. The atoms of metal are opaque to electrons and the viruses are seen as suspended in a dark background of metal atoms. [29] This technique has been in use since the 1950s. [31] Many viruses were discovered using this technique and negative staining electron microscopy is still a valuable weapon in a virologist's arsenal. [32]

Traditional electron microscopy has disadvantages in that viruses are damaged by drying in the high vacuum inside the electron microscope and the electron beam itself is destructive. [29] In cryogenic electron microscopy the structure of viruses is preserved by embedding them in an environment of vitreous water. [33] This allows the determination of biomolecular structures at near-atomic resolution, [34] and has attracted wide attention to the approach as an alternative to X-ray crystallography or NMR spectroscopy for the determination of the structure of viruses. [35]

Cryoelectron micrograph of a rotavirus Rotavirus Reconstruction.jpg
Cryoelectron micrograph of a rotavirus

Growth in cultures

Viruses are obligate intracellular parasites and because they only reproduce inside the living cells of a host these cells are needed to grow them in the laboratory. For viruses that infect animals (usually called "animal viruses") cells grown in laboratory cell cultures are used. In the past, fertile hens' eggs were used and the viruses were grown on the membranes surrounding the embryo. This method is still used in the manufacture of some vaccines. For the viruses that infect bacteria, the bacteriophages, the bacteria growing in test tubes can be used directly. For plant viruses, the natural host plants can be used or, particularly when the infection is not obvious, so-called indicator plants, which show signs of infection more clearly. [36] [37]

Cytopathic effect of herpes simplex virus. The infected cells have become round and balloon-like. CPE rounding.jpg
Cytopathic effect of herpes simplex virus. The infected cells have become round and balloon-like.

Viruses that have grown in cell cultures can be indirectly detected by the detrimental effect they have on the host cell. These cytopathic effects are often characteristic of the type of virus. For instance, herpes simplex viruses produce a characteristic "ballooning" of the cells, typically human fibroblasts. Some viruses, such as mumps virus cause red blood cells from chickens to firmly attach to the infected cells. This is called "haemadsorption" or "hemadsorption". Some viruses produce localised "lesions" in cell layers called plaques, which are useful in quantitation assays and in identifying the species of virus by plaque reduction assays. [38] [39]

Viruses growing in cell cultures are used to measure their susceptibility to validated and novel antiviral drugs. [40]


Viruses are antigens that induce the production of antibodies and these antibodies can be used in laboratories to study viruses. Related viruses often react with each other's antibodies and some viruses can be named based on the antibodies they react with. The use of the antibodies which were once exclusively derived from the serum (blood fluid) of animals is called serology. [41] Once an antibody–reaction has taken place in a test, other methods are needed to confirm this. Older methods included complement fixation tests, [42] hemagglutination inhibition and virus neutralisation. [43] Newer methods use enzyme immunoassays (EIA). [44]

In the years before PCR was invented immunofluorescence was used to quickly confirm viral infections. It is an infectivity assay that is virus species specific because antibodies are used. The antibodies are tagged with a dye that is luminescencent and when using an optical microscope with a modified light source, infected cells glow in the dark. [45]

Polymerase chain reaction (PCR) and other nucleic acid detection methods

PCR is a mainstay method for detecting viruses in all species including plants and animals. It works by detecting traces of virus specific RNA or DNA. It is very sensitive and specific, but can be easily compromised by contamination. Most of the tests used in veterinary virology and medical virology are based on PCR or similar methods such as transcription mediated amplification. When a novel virus emerges, such as the covid coronavirus, a specific test can be devised quickly so long as the viral genome has been sequenced and unique regions of the viral DNA or RNA identified. [46] The invention of microfluidic tests as allowed for most of these tests to be automated, [47] Despite its specificity and sensitivity, PCR has a disadvantage in that it does not differentiate infectious and non-infectious viruses and "tests of cure" have to be delayed for up to 21 days to allow for residual viral nucleic acid to clear from the site of the infection. [48]

Diagnostic tests

In laboratories many of the diagnostic test for detecting viruses are nucleic acid amplification methods such as PCR. Some tests detect the viruses or their components as these include electron microscopy and enzyme-immunoassays. The so-called "home" or "self"-testing gadgets are usually lateral flow tests, which detect the virus using a tagged monoclonal antibody. [49] These are also used in agriculture, food and environmental sciences. [50]

Quantitation and viral loads

Counting viruses (quantitation) has always had an important role in virology and has become central to the control of some infections of humans where the viral load is measured. [51] There are two basic methods: those that count the fully infective virus particles, which are called infectivity assays, and those that count all the particles including the defective ones. [29]

Infectivity assays

Plaques in cells caused herpes simplex virus. The cells have been fixed and stained blue. Plaque assay macro.jpg
Plaques in cells caused herpes simplex virus. The cells have been fixed and stained blue.

Infectivity assays measure the amount (concentration) of infective viruses in a sample of known volume. [52] For host cells, plants or cultures of bacterial or animal cells are used. Laboratory animals such as mice have also been used particularly in veterinary virology. [53] These are assays are either quantitative where the results are on a continuous scale or quantal, where an event either occurs or it does not. Quantitative assays give absolute values and quantal assays give a statistical probability such as the volume of the test sample needed to ensure 50% of the hosts cells, plants or animals are infected. This is called the median infectious dose or ID 50. [54] Infective bacteriophages can be counted by seeding them onto "lawns" of bacteria in culture dishes. When at low concentrations, the viruses form holes in the lawn that can be counted. The number of viruses is then expressed as plaque forming units. For the bacteriophages that reproduce in bacteria that cannot be grown in cultures, viral load assays are used. [55]

Immunoflourescence: Cells infected by rotavirus (top) and uninfected cells (bottom) Virus Infected Cells.jpg
Immunoflourescence: Cells infected by rotavirus (top) and uninfected cells (bottom)

The focus forming assay (FFA) is a variation of the plaque assay, but instead of relying on cell lysis in order to detect plaque formation, the FFA employs immunostaining techniques using fluorescently labeled antibodies specific for a viral antigen to detect infected host cells and infectious virus particles before an actual plaque is formed. The FFA is particularly useful for quantifying classes of viruses that do not lyse the cell membranes, as these viruses would not be amenable to the plaque assay. Like the plaque assay, host cell monolayers are infected with various dilutions of the virus sample and allowed to incubate for a relatively brief incubation period (e.g., 24–72 hours) under a semisolid overlay medium that restricts the spread of infectious virus, creating localized clusters (foci) of infected cells. Plates are subsequently probed with fluorescently labeled antibodies against a viral antigen, and fluorescence microscopy is used to count and quantify the number of foci. The FFA method typically yields results in less time than plaque or fifty-percent-tissue-culture-infective-dose (TCID50) assays, but it can be more expensive in terms of required reagents and equipment. Assay completion time is also dependent on the size of area that the user is counting. A larger area will require more time but can provide a more accurate representation of the sample. Results of the FFA are expressed as focus forming units per milliliter, or FFU/ [56]

Viral load assays

When an assay for measuring the infective virus particle is done (Plaque assay, Focus assay), viral titre often refers to the concentration of infectious viral particles, which is different from the total viral particles. Viral load assays usually count the number of viral genomes present rather than the number of particles and use methods similar to PCR. [57] Viral load tests are an important in the control of infections by HIV. [58] This versatile method can be used for plant viruses. [59] [60]

Molecular biology

Molecular virology is the study of viruses at the level of nucleic acids and proteins. The methods invented by molecular biologists have all proven useful in virology. Their small sizes and relatively simple structures make viruses an ideal candidate for study by these techniques.

Purifying viruses and their components

Caesium chloride (CsCl) solution and two morphological types of rotavirus. Following centrifugation at 100 g a density gradient forms in the CsCl solution and the virus particles separate according to their densities. The tube is 10 cm tall. The viruses are the two "milky" zones close together. CsCl density gradient centrifugation.jpg
Caesium chloride (CsCl) solution and two morphological types of rotavirus. Following centrifugation at 100 g a density gradient forms in the CsCl solution and the virus particles separate according to their densities. The tube is 10 cm tall. The viruses are the two "milky" zones close together.

For further study, viruses grown in the laboratory need purifying to remove contaminants from the host cells. The methods used often have the advantage of concentrating the viruses, which makes it easier to investigate them.


Centrifuges are often used to purify viruses. Low speed centrifuges, i.e. those with a top speed of 10,000 revolutions per minute (rpm) are not powerful enough to concentrate viruses, but ultracentrifuges with a top speed of around 100,000 rpm, are and this difference is used in a method called differential centrifugation. In this method the larger and heavier contaminants are removed from a virus mixture by low speed centrifugation. The viruses, which are small and light and are left in suspension, are then concentrated by high speed centrifugation. [62]

Following differential centrifugation, virus suspensions often remain contaminated with debris that has the same sedimentation coefficient and are not removed by the procedure. In these cases a modification of centrifugation, called buoyant density centrifugation, is used. In this method the viruses recovered from differential centrifugation are centrifuged again at very high speed for several hours in dense solutions of sugars or salts that form a density gradient, from low to high, in the tube during the centrifugation. In some cases, preformed gradients are used where solutions of steadily decreasing density are carefully overlaid on each other. Like an object in the Dead Sea, despite the centrifugal force the virus particles cannot sink into solutions that are more dense than they are and they form discrete layers of, often visible, concentrated viruses in the tube. Caesium chloride is often used for these solutions as it is relatively inert but easily self-forms a gradient when centrifuged at high speed in an ultracentrifuge. [61] Buoyant density centrifugation can also be used to purify the components of viruses such as their nucleic acids or proteins. [63]


Polyacrylamide gel electrophoresis of rotavirus proteins stained with Coomassie blue Coomassie blue stained gel.png
Polyacrylamide gel electrophoresis of rotavirus proteins stained with Coomassie blue

The separation of molecules based on their electric charge is called electrophoresis. Viruses and all their components can be separated and purified using this method. This is usually done in a supporting medium such as agarose and polyacrylamide gels. The separated molecules are revealed using stains such as coomasie blue, for proteins, or ethidium bromide for nucleic acids. In some instances the viral components are rendered radioactive before electrophoresis and are revealed using photographic film in a process known as autoradiography. [64]

Sequencing of viral genomes

As most viruses are too small to be seen by a light microscope, sequencing is one of the main tools in virology to identify and study the virus. Traditional Sanger sequencing and next-generation sequencing (NGS) are used to sequence viruses in basic and clinical research, as well as for the diagnosis of emerging viral infections, molecular epidemiology of viral pathogens, and drug-resistance testing. There are more than 2.3 million unique viral sequences in GenBank. [65] NGS has surpassed traditional Sanger as the most popular approach for generating viral genomes. [65] Viral genome sequencing as become a central method in viral epidemiology and viral classification.

Phylogenetic analysis

Data from the sequencing of viral genomes can be used to determine evolutionary relationships and this is called phylogenetic analysis. [66] Software, such as PHYLIP, is used to draw phylogenetic trees. This analysis is also used in studying the spread of viral infections in communities (epidemiology). [67]


When purified viruses or viral components are needed for diagnostic tests or vaccines, cloning can be used instead of growing the viruses. [68] At the start of the COVID-19 pandemic the availability of the severe acute respiratory syndrome coronavirus 2 RNA sequence enabled tests to be manufactured quickly. [69] There are several proven methods for cloning viruses and their components. Small pieces of DNA called cloning vectors are often used and the most common ones are laboratory modified plasmids (small circular molecules of DNA produced by bacteria). The viral nucleic acid, or a part of it, is inserted in the plasmid, which is the copied many times over by bacteria. This recombinant DNA can then be used to produce viral components without the need for native viruses. [70]

Phage virology

The viruses that reproduce in bacteria, archaea and fungi are informally called "phages", [71] and the ones that infect bacteria – bacteriophages – in particular are useful in virology and biology in general. [72] Bacteriophages were some of the first viruses to be discovered, early in the twentieth century, [73] and because they are relatively easy to grow quickly in laboratories, much of our understanding of viruses originated by studying them. [73] Bacteriophages, long known for their positive effects in the environment, are used in phage display techniques for screening proteins DNA sequences. They are a powerful tool in molecular biology. [74]


All viruses have genes which are studied using genetics. [75] All the techniques used in molecular biology, such as cloning, creating mutations RNA silencing are used in viral genetics. [76]


Reassortment is the switching of genes from different parents and it is particularly useful when studying the genetics of viruses that have segmented genomes (fragmented into two or more nucleic acid molecules) such as influenza viruses and rotaviruses. The genes that encode properties such as serotype can be identified in this way. [77]


Often confused with reassortment, recombination is also the mixing of genes but the mechanism differs in that stretches of DNA or RNA molecules, as opposed to the full molecules, are joined during the RNA or DNA replication cycle. Recombination is not as common as reassortment in nature but it is a powerful tool in laboratories for studying the structure and functions of viral genes. [78]

Reverse genetics

Reverse genetics is a powerful research method in virology. [79] In this procedure complementary DNA (cDNA) copies of virus genomes called "infectious clones" are used to produce genetically modified viruses that can be then tested for changes in say, virulence or transmissibility. [80]

Virus classification

A major branch of virology is virus classification. It is artificial in that it is not based on evolutionary phylogenetics but it is based shared or distinguishing properties of viruses. [81] [82] It seeks to describe the diversity of viruses by naming and grouping them on the basis of similarities. [83] In 1962, André Lwoff, Robert Horne, and Paul Tournier were the first to develop a means of virus classification, based on the Linnaean hierarchical system. [84] This system based classification on phylum, class, order, family, genus, and species. Viruses were grouped according to their shared properties (not those of their hosts) and the type of nucleic acid forming their genomes. [85] In 1966, the International Committee on Taxonomy of Viruses (ICTV) was formed. The system proposed by Lwoff, Horne and Tournier was initially not accepted by the ICTV because the small genome size of viruses and their high rate of mutation made it difficult to determine their ancestry beyond order. As such, the Baltimore classification system has come to be used to supplement the more traditional hierarchy. [86] Starting in 2018, the ICTV began to acknowledge deeper evolutionary relationships between viruses that have been discovered over time and adopted a 15-rank classification system ranging from realm to species. [87] Additionally, some species within the same genus are grouped into a genogroup. [88] [89]

ICTV classification

The ICTV developed the current classification system and wrote guidelines that put a greater weight on certain virus properties to maintain family uniformity. A unified taxonomy (a universal system for classifying viruses) has been established. Only a small part of the total diversity of viruses has been studied. [90] As of 2021, 6 realms, 10 kingdoms, 17 phyla, 2 subphyla, 39 classes, 65 orders, 8 suborders, 233 families, 168 subfamilies, 2,606 genera, 84 subgenera, and 10,434 species of viruses have been defined by the ICTV. [91]

The general taxonomic structure of taxon ranges and the suffixes used in taxonomic names are shown hereafter. As of 2021, the ranks of subrealm, subkingdom, and subclass are unused, whereas all other ranks are in use. [91]

Realm (-viria)
Subrealm (-vira)
Kingdom (-virae)
Subkingdom (-virites)
Phylum (-viricota)
Subphylum (-viricotina)
Class (-viricetes)
Subclass (-viricetidae)
Order (-virales)
Suborder (-virineae)
Family (-viridae)
Subfamily (-virinae)
Genus (-virus)
Subgenus (-virus)

Baltimore classification

The Baltimore Classification of viruses is based on the method of viral mRNA synthesis. VirusBaltimoreClassification.svg
The Baltimore Classification of viruses is based on the method of viral mRNA synthesis.

The Nobel Prize-winning biologist David Baltimore devised the Baltimore classification system. [92]

The Baltimore classification of viruses is based on the mechanism of mRNA production. Viruses must generate mRNAs from their genomes to produce proteins and replicate themselves, but different mechanisms are used to achieve this in each virus family. Viral genomes may be single-stranded (ss) or double-stranded (ds), RNA or DNA, and may or may not use reverse transcriptase (RT). In addition, ssRNA viruses may be either sense (+) or antisense (−). This classification places viruses into seven groups:

Related Research Articles

<span class="mw-page-title-main">Bacteriophage</span> Virus that infects and replicates within bacteria

A bacteriophage, also known informally as a phage, is a virus that infects and replicates within bacteria and archaea. The term was derived from "bacteria" and the Greek φαγεῖν, meaning "to devour". Bacteriophages are composed of proteins that encapsulate a DNA or RNA genome, and may have structures that are either simple or elaborate. Their genomes may encode as few as four genes and as many as hundreds of genes. Phages replicate within the bacterium following the injection of their genome into its cytoplasm.

<span class="mw-page-title-main">Poliovirus</span> Enterovirus

Poliovirus, the causative agent of polio, is a serotype of the species Enterovirus C, in the family of Picornaviridae. There are three poliovirus serotypes: types 1, 2, and 3.

Viral evolution is a subfield of evolutionary biology and virology that is specifically concerned with the evolution of viruses. Viruses have short generation times, and many—in particular RNA viruses—have relatively high mutation rates. Although most viral mutations confer no benefit and often even prove deleterious to viruses, the rapid rate of viral mutation combined with natural selection allows viruses to quickly adapt to changes in their host environment. In addition, because viruses typically produce many copies in an infected host, mutated genes can be passed on to many offspring quickly. Although the chance of mutations and evolution can change depending on the type of virus, viruses overall have high chances for mutations.

<span class="mw-page-title-main">Plant virus</span> Virus that affects plants

Plant viruses are viruses that affect plants. Like all other viruses, plant viruses are obligate intracellular parasites that do not have the molecular machinery to replicate without a host. Plant viruses can be pathogenic to vascular plants.

<span class="mw-page-title-main">Lysogenic cycle</span> Process of virus reproduction

Lysogeny, or the lysogenic cycle, is one of two cycles of viral reproduction. Lysogeny is characterized by integration of the bacteriophage nucleic acid into the host bacterium's genome or formation of a circular replicon in the bacterial cytoplasm. In this condition the bacterium continues to live and reproduce normally, while the bacteriophage lies in a dormant state in the host cell. The genetic material of the bacteriophage, called a prophage, can be transmitted to daughter cells at each subsequent cell division, and later events can release it, causing proliferation of new phages via the lytic cycle.

The murine leukemia viruses are retroviruses named for their ability to cause cancer in murine (mouse) hosts. Some MLVs may infect other vertebrates. MLVs include both exogenous and endogenous viruses. Replicating MLVs have a positive sense, single-stranded RNA (ssRNA) genome that replicates through a DNA intermediate via the process of reverse transcription.

<span class="mw-page-title-main">Astrovirus</span> Family of viruses

Astroviruses (Astroviridae) are a type of virus that was first discovered in 1975 using electron microscopes following an outbreak of diarrhea in humans. In addition to humans, astroviruses have now been isolated from numerous mammalian animal species and from avian species such as ducks, chickens, and turkey poults. Astroviruses are 28–35 nm diameter, icosahedral viruses that have a characteristic five- or six-pointed star-like surface structure when viewed by electron microscopy. Along with the Picornaviridae and the Caliciviridae, the Astroviridae comprise a third family of nonenveloped viruses whose genome is composed of plus-sense, single-stranded RNA. Astrovirus has a non-segmented, single stranded, positive sense RNA genome within a non-enveloped icosahedral capsid. Human astroviruses have been shown in numerous studies to be an important cause of gastroenteritis in young children worldwide. In animals, Astroviruses also cause infection of the gastrointestinal tract but may also result in encephalitis, hepatitis (avian) and nephritis (avian).

<span class="mw-page-title-main">Medical microbiology</span> Branch of medical science

Medical microbiology, the large subset of microbiology that is applied to medicine, is a branch of medical science concerned with the prevention, diagnosis and treatment of infectious diseases. In addition, this field of science studies various clinical applications of microbes for the improvement of health. There are four kinds of microorganisms that cause infectious disease: bacteria, fungi, parasites and viruses, and one type of infectious protein called prion.

<span class="mw-page-title-main">Introduction to viruses</span> Non-technical introduction to viruses

A virus is a tiny infectious agent that reproduces inside the cells of living hosts. When infected, the host cell is forced to rapidly produce thousands of identical copies of the original virus. Unlike most living things, viruses do not have cells that divide; new viruses assemble in the infected host cell. But unlike simpler infectious agents like prions, they contain genes, which allow them to mutate and evolve. Over 4,800 species of viruses have been described in detail out of the millions in the environment. Their origin is unclear: some may have evolved from plasmids—pieces of DNA that can move between cells—while others may have evolved from bacteria.

In the diagnostic laboratory, virus infections can be confirmed by a myriad of methods. Diagnostic virology has changed rapidly due to the advent of molecular techniques and increased clinical sensitivity of serological assays.

<span class="mw-page-title-main">History of virology</span> Aspect of history

The history of virology – the scientific study of viruses and the infections they cause – began in the closing years of the 19th century. Although Edward Jenner and Louis Pasteur developed the first vaccines to protect against viral infections, they did not know that viruses existed. The first evidence of the existence of viruses came from experiments with filters that had pores small enough to retain bacteria. In 1892, Dmitri Ivanovsky used one of these filters to show that sap from a diseased tobacco plant remained infectious to healthy tobacco plants despite having been filtered. Martinus Beijerinck called the filtered, infectious substance a "virus" and this discovery is considered to be the beginning of virology.

<span class="mw-page-title-main">Virus</span> Infectious agent that replicates in cells

A virus is a submicroscopic infectious agent that replicates only inside the living cells of an organism. Viruses infect all life forms, from animals and plants to microorganisms, including bacteria and archaea. Viruses are found in almost every ecosystem on Earth and are the most numerous type of biological entity. Since Dmitri Ivanovsky's 1892 article describing a non-bacterial pathogen infecting tobacco plants and the discovery of the tobacco mosaic virus by Martinus Beijerinck in 1898, more than 11,000 of the millions of virus species have been described in detail. The study of viruses is known as virology, a subspeciality of microbiology.

<i>Picobirnavirus</i> Genus of viruses

Picobirnavirus is a genus of double-stranded RNA viruses. It is the only genus in the family Picobirnaviridae. Although amniotes, especially mammals, were thought to serve as hosts, it has been recently suggested that these viruses might infect bacteria and possibly some other invertebrates. If they do infect bacteria, then they are Bacteriophages. There are three species in this genus. Associated symptoms include gastroenteritis in animals and humans, though the disease association is unclear.

Virus quantification is counting or calculating the number of virus particles (virions) in a sample to determine the virus concentration. It is used in both research and development (R&D) in academic and commercial laboratories as well as in production situations where the quantity of virus at various steps is an important variable that must be monitored. For example, the production of virus-based vaccines, recombinant proteins using viral vectors, and viral antigens all require virus quantification to continually monitor and/or modify the process in order to optimize product quality and production yields and to respond to ever changing demands and applications. Other examples of specific instances where viruses need to be quantified include clone screening, multiplicity of infection (MOI) optimization, and adaptation of methods to cell culture.

In biology, a pathogen, in the oldest and broadest sense, is any organism or agent that can produce disease. A pathogen may also be referred to as an infectious agent, or simply a germ.

<span class="mw-page-title-main">Human virome</span> Total collection of viruses in and on the human body

The human virome is the total collection of viruses in and on the human body. Viruses in the human body may infect both human cells and other microbes such as bacteria. Some viruses cause disease, while others may be asymptomatic. Certain viruses are also integrated into the human genome as proviruses or endogenous viral elements.

Synthetic virology is a branch of virology engaged in the study and engineering of synthetic man-made viruses. It is a multidisciplinary research field at the intersection of virology, synthetic biology, computational biology, and DNA nanotechnology, from which it borrows and integrates its concepts and methodologies. There is a wide range of applications for synthetic viral technology such as medical treatments, investigative tools, and reviving organisms.

Aichivirus A formerly Aichi virus (AiV) belongs to the genus Kobuvirus in the family Picornaviridae. Six species are apart of the genus Kobuvirus, Aichivirus A-F. Within Aichivirus A, there are six different types including human Aichi virus, canine kobuvirus, murine kobuvirus, Kathmandu sewage kobuvirus, roller kobuvirus, and feline kobuvirus. Three different genotypes are found in human Aichi virus, represented as genotype A, B, and C.

This glossary of virology is a list of definitions of terms and concepts used in virology, the study of viruses, particularly in the description of viruses and their actions. Related fields include microbiology, molecular biology, and genetics.

<span class="mw-page-title-main">Marine viruses</span> Viruses found in marine environments

Marine viruses are defined by their habitat as viruses that are found in marine environments, that is, in the saltwater of seas or oceans or the brackish water of coastal estuaries. Viruses are small infectious agents that can only replicate inside the living cells of a host organism, because they need the replication machinery of the host to do so. They can infect all types of life forms, from animals and plants to microorganisms, including bacteria and archaea.


  1. 1 2 Dolja VV, Koonin EV (November 2011). "Common origins and host-dependent diversity of plant and animal viromes". Current Opinion in Virology. 1 (5): 322–31. doi:10.1016/j.coviro.2011.09.007. PMC   3293486 . PMID   22408703.
  2. 1 2 Novella IS, Presloid JB, Taylor RT (December 2014). "RNA replication errors and the evolution of virus pathogenicity and virulence". Current Opinion in Virology. 9: 143–7. doi:10.1016/j.coviro.2014.09.017. PMID   25462446.
  3. 1 2 Sales RK, Oraño J, Estanislao RD, Ballesteros AJ, Gomez MI (2021-04-29). "Research priority-setting for human, plant, and animal virology: an online experience for the Virology Institute of the Philippines". Health Research Policy and Systems. 19 (1): 70. doi: 10.1186/s12961-021-00723-z . ISSN   1478-4505. PMC   8082216 . PMID   33926472.
  4. Bordenave G (May 2003). "Louis Pasteur (1822-1895)". Microbes and Infection. 5 (6): 553–60. doi:10.1016/S1286-4579(03)00075-3. PMID   12758285.
  5. Shors pp. 74, 827
  6. 1 2 Collier p. 3
  7. Dimmock p. 4
  8. Dimmock pp. 4–5
  9. Fenner F (2009). Mahy BW, Van Regenmortal MH (eds.). Desk Encyclopedia of General Virology (1 ed.). Oxford: Academic Press. p. 15. ISBN   978-0-12-375146-1.
  10. Shors p. 827
  11. D'Herelle F (September 2007). "On an invisible microbe antagonistic toward dysenteric bacilli: brief note by Mr. F. D'Herelle, presented by Mr. Roux. 1917". Research in Microbiology. 158 (7): 553–54. doi: 10.1016/j.resmic.2007.07.005 . PMID   17855060.
  12. Domingo-Calap P, Georgel P, Bahram S (March 2016). "Back to the future: bacteriophages as promising therapeutic tools". HLA. 87 (3): 133–40. doi:10.1111/tan.12742. PMID   26891965. S2CID   29223662.
  13. Steinhardt E, Israeli C, Lambert RA (1913). "Studies on the cultivation of the virus of vaccinia". The Journal of Infectious Diseases. 13 (2): 294–300. doi:10.1093/infdis/13.2.294.
  14. Collier p. 4
  15. Goodpasture EW, Woodruff AM, Buddingh GJ (October 1931). "The cultivation of vaccine and other viruses in the chorioallantoic membrane of chick embryos". Science. 74 (1919): 371–72. Bibcode:1931Sci....74..371G. doi:10.1126/science.74.1919.371. PMID   17810781.
  16. Thomas Huckle Weller (2004). Growing Pathogens in Tissue Cultures: Fifty Years in Academic Tropical Medicine, Pediatrics, and Virology. Boston Medical Library. p. 57. ISBN   978-0-88135-380-8.
  17. Rosen FS (October 2004). "Isolation of poliovirus--John Enders and the Nobel Prize". The New England Journal of Medicine. 351 (15): 1481–83. doi:10.1056/NEJMp048202. PMID   15470207.
  18. Frängsmyr T, Ekspång G, eds. (1993). Nobel Lectures, Physics 1981–1990. Singapore: World Scientific Publishing Co.
    • In 1887, Buist visualised one of the largest, Vaccinia virus, by optical microscopy after staining it. Vaccinia was not known to be a virus at that time. (Buist J.B. Vaccinia and Variola: a study of their life history Churchill, London)
  19. Stanley WM, Loring HS (January 1936). "The Isolation of Crystalline Tobacco Mosaic Virus Protein From Diseased Tomato Plants". Science. 83 (2143): 85. Bibcode:1936Sci....83...85S. doi:10.1126/science.83.2143.85. PMID   17756690.
  20. Stanley WM, Lauffer MA (April 1939). "Disintegration of Tobacco Mosaic Virus in Urea Solutions". Science. 89 (2311): 345–47. Bibcode:1939Sci....89..345S. doi:10.1126/science.89.2311.345. PMID   17788438.
  21. Creager AN, Morgan GJ (June 2008). "After the double helix: Rosalind Franklin's research on Tobacco mosaic virus". Isis. 99 (2): 239–72. doi:10.1086/588626. PMID   18702397. S2CID   25741967.
  22. Dimmock p. 12
  23. Norrby E (2008). "Nobel Prizes and the emerging virus concept". Archives of Virology. 153 (6): 1109–23. doi:10.1007/s00705-008-0088-8. PMID   18446425. S2CID   10595263.
  24. Collier p. 745
  25. Temin HM, Baltimore D (1972). "RNA-directed DNA synthesis and RNA tumor viruses". Advances in Virus Research. 17: 129–86. doi:10.1016/S0065-3527(08)60749-6. ISBN   9780120398171. PMID   4348509.
  26. Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, et al. (May 1983). "Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)". Science. 220 (4599): 868–71. Bibcode:1983Sci...220..868B. doi:10.1126/science.6189183. PMID   6189183.
  27. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (April 1989). "Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome". Science. 244 (4902): 359–62. Bibcode:1989Sci...244..359C. CiteSeerX . doi:10.1126/science.2523562. PMID   2523562.
  28. Houghton M (November 2009). "The long and winding road leading to the identification of the hepatitis C virus". Journal of Hepatology. 51 (5): 939–48. doi: 10.1016/j.jhep.2009.08.004 . PMID   19781804.
  29. 1 2 3 4 Payne S. Methods to Study Viruses. Viruses. 2017;37-52. doi:10.1016/B978-0-12-803109-4.00004-0
  30. "Magnification - Microscopy, size and magnification (CCEA) - GCSE Biology (Single Science) Revision - CCEA". BBC Bitesize. Retrieved 2023-01-02.
  31. Brenner S, Horne RW (July 1959). "A negative staining method for high resolution electron microscopy of viruses". Biochimica et Biophysica Acta. 34: 103–10. doi:10.1016/0006-3002(59)90237-9. PMID   13804200.
  32. Goldsmith CS, Miller SE (October 2009). "Modern uses of electron microscopy for detection of viruses". Clinical Microbiology Reviews. 22 (4): 552–63. doi:10.1128/CMR.00027-09. PMC   2772359 . PMID   19822888.
  33. Tivol WF, Briegel A, Jensen GJ (October 2008). "An Improved Cryogen for Plunge Freezing". Microscopy and Microanalysis. 14 (5): 375–379. Bibcode:2008MiMic..14..375T. doi:10.1017/S1431927608080781. ISSN   1431-9276. PMC   3058946 . PMID   18793481.
  34. Cheng Y, Grigorieff N, Penczek PA, Walz T (April 2015). "A primer to single-particle cryo-electron microscopy". Cell. 161 (3): 438–449. doi:10.1016/j.cell.2015.03.050. PMC   4409659 . PMID   25910204.
  35. Stoddart C (1 March 2022). "Structural biology: How proteins got their close-up". Knowable Magazine. doi: 10.1146/knowable-022822-1 . Retrieved 25 March 2022.
  36. Liu JZ, Richerson K, Nelson RS (August 2009). "Growth conditions for plant virus-host studies". Current Protocols in Microbiology. Chapter 16: Unit16A.1. doi:10.1002/9780471729259.mc16a01s14. PMID   19653216. S2CID   41236532.
  37. Valmonte-Cortes GR, Lilly ST, Pearson MN, Higgins CM, MacDiarmid RM (January 2022). "The Potential of Molecular Indicators of Plant Virus Infection: Are Plants Able to Tell Us They Are Infected?". Plants. 11 (2): 188. doi: 10.3390/plants11020188 . PMC   8777591 . PMID   35050076.
  38. Gauger PC, Vincent AL (2014). "Serum Virus Neutralization Assay for Detection and Quantitation of Serum-Neutralizing Antibodies to Influenza a Virus in Swine". Animal Influenza Virus. Methods in Molecular Biology. Vol. 1161. pp. 313–24. doi:10.1007/978-1-4939-0758-8_26. ISBN   978-1-4939-0757-1. PMID   24899440.
  39. Dimitrova K, Mendoza EJ, Mueller N, Wood H (2020). "A Plaque Reduction Neutralization Test for the Detection of ZIKV-Specific Antibodies". Zika Virus. Methods in Molecular Biology. Vol. 2142. pp. 59–71. doi:10.1007/978-1-0716-0581-3_5. ISBN   978-1-0716-0580-6. PMID   32367358. S2CID   218504421.
  40. Lampejo T (July 2020). "Influenza and antiviral resistance: an overview". European Journal of Clinical Microbiology & Infectious Diseases. 39 (7): 1201–1208. doi:10.1007/s10096-020-03840-9. PMC   7223162 . PMID   32056049.
  41. Zainol Rashid Z, Othman SN, Abdul Samat MN, Ali UK, Wong KK (April 2020). "Diagnostic performance of COVID-19 serology assays". The Malaysian Journal of Pathology. 42 (1): 13–21. PMID   32342927.
  42. Swack NS, Gahan TF, Hausler WJ (August 1992). "The present status of the complement fixation test in viral serodiagnosis". Infectious Agents and Disease. 1 (4): 219–24. PMID   1365549.
  43. Smith TJ (August 2011). "Structural studies on antibody recognition and neutralization of viruses". Current Opinion in Virology. 1 (2): 150–6. doi:10.1016/j.coviro.2011.05.020. PMC   3163491 . PMID   21887208.
  44. Mahony JB, Petrich A, Smieja M (2011). "Molecular diagnosis of respiratory virus infections". Critical Reviews in Clinical Laboratory Sciences. 48 (5–6): 217–49. doi:10.3109/10408363.2011.640976. PMID   22185616. S2CID   24960083.
  45. AbuSalah MA, Gan SH, Al-Hatamleh MA, Irekeola AA, Shueb RH, Yean Yean C (March 2020). "Recent Advances in Diagnostic Approaches for Epstein-Barr Virus". Pathogens. 9 (3): 226. doi: 10.3390/pathogens9030226 . PMC   7157745 . PMID   32197545.
  46. Zhu H, Zhang H, Xu Y, Laššáková S, Korabečná M, Neužil P (October 2020). "PCR past, present and future". BioTechniques. 69 (4): 317–325. doi:10.2144/btn-2020-0057. PMC   7439763 . PMID   32815744.
  47. Wang X, Hong XZ, Li YW, Li Y, Wang J, Chen P, Liu BF (March 2022). "Microfluidics-based strategies for molecular diagnostics of infectious diseases". Military Medical Research. 9 (1): 11. doi: 10.1186/s40779-022-00374-3 . PMC   8930194 . PMID   35300739.
  48. Benzigar MR, Bhattacharjee R, Baharfar M, Liu G (April 2021). "Current methods for diagnosis of human coronaviruses: pros and cons". Analytical and Bioanalytical Chemistry. 413 (9): 2311–2330. doi:10.1007/s00216-020-03046-0. PMC   7679240 . PMID   33219449.
  49. Burrell CJ, Howard CR, Murphy FA (2017-01-01), Burrell CJ, Howard CR, Murphy FA (eds.), "Chapter 10 - Laboratory Diagnosis of Virus Diseases", Fenner and White's Medical Virology (Fifth Edition), London: Academic Press, pp. 135–154, doi:10.1016/b978-0-12-375156-0.00010-2, ISBN   978-0-12-375156-0, PMC   7149825
  50. Koczula KM, Gallotta A (June 2016). "Lateral flow assays". Essays in Biochemistry. 60 (1): 111–20. doi:10.1042/EBC20150012. PMC   4986465 . PMID   27365041.
  51. Lee MJ (October 2021). "Quantifying SARS-CoV-2 viral load: current status and future prospects". Expert Review of Molecular Diagnostics. 21 (10): 1017–1023. doi:10.1080/14737159.2021.1962709. PMC   8425446 . PMID   34369836.
  52. Mistry BA, D'Orsogna MR, Chou T (June 2018). "The Effects of Statistical Multiplicity of Infection on Virus Quantification and Infectivity Assays". Biophysical Journal. 114 (12): 2974–2985. arXiv: 1805.02810 . Bibcode:2018BpJ...114.2974M. doi:10.1016/j.bpj.2018.05.005. PMC   6026352 . PMID   29925033.
  53. Kashuba C, Hsu C, Krogstad A, Franklin C (January 2005). "Small mammal virology". The Veterinary Clinics of North America. Exotic Animal Practice. 8 (1): 107–22. doi:10.1016/j.cvex.2004.09.004. PMC   7110861 . PMID   15585191.
  54. Cutler TD, Wang C, Hoff SJ, Kittawornrat A, Zimmerman JJ (August 2011). "Median infectious dose (ID50) of porcine reproductive and respiratory syndrome virus isolate MN-184 via aerosol exposure". Veterinary Microbiology. 151 (3–4): 229–37. doi:10.1016/j.vetmic.2011.03.003. PMID   21474258.
  55. Moon K, Cho JC (March 2021). "Metaviromics coupled with phage-host identification to open the viral "black box"". Journal of Microbiology (Seoul, Korea). 59 (3): 311–323. doi:10.1007/s12275-021-1016-9. PMID   33624268. S2CID   232023531.
  56. Salgado EN, Upadhyayula S, Harrison SC (September 2017). "Single-Particle Detection of Transcription following Rotavirus Entry". Journal of Virology. 91 (18). doi:10.1128/JVI.00651-17. PMC   5571246 . PMID   28701394.
  57. Yokota I, Hattori T, Shane PY, Konno S, Nagasaka A, Takeyabu K, Fujisawa S, Nishida M, Teshima T (February 2021). "Equivalent SARS-CoV-2 viral loads by PCR between nasopharyngeal swab and saliva in symptomatic patients". Scientific Reports. 11 (1): 4500. Bibcode:2021NatSR..11.4500Y. doi:10.1038/s41598-021-84059-2. PMC   7904914 . PMID   33627730.
  58. Nichols BE, Girdwood SJ, Crompton T, Stewart-Isherwood L, Berrie L, Chimhamhiwa D, Moyo C, Kuehnle J, Stevens W, Rosen S (September 2019). "Monitoring viral load for the last mile: what will it cost?". Journal of the International AIDS Society. 22 (9): e25337. doi:10.1002/jia2.25337. PMC   6742838 . PMID   31515967.
  59. Shirima RR, Maeda DG, Kanju E, Ceasar G, Tibazarwa FI, Legg JP (July 2017). "Absolute quantification of cassava brown streak virus mRNA by real-time qPCR". Journal of Virological Methods. 245: 5–13. doi:10.1016/j.jviromet.2017.03.003. PMC   5429390 . PMID   28315718.
  60. Rubio L, Galipienso L, Ferriol I (2020). "Detection of Plant Viruses and Disease Management: Relevance of Genetic Diversity and Evolution". Frontiers in Plant Science. 11: 1092. doi: 10.3389/fpls.2020.01092 . PMC   7380168 . PMID   32765569.
  61. 1 2 Beards GM (August 1982). "A method for the purification of rotaviruses and adenoviruses from faeces". Journal of Virological Methods. 4 (6): 343–52. doi:10.1016/0166-0934(82)90059-3. PMID   6290520.
  62. Zhou Y, McNamara RP, Dittmer DP (August 2020). "Purification Methods and the Presence of RNA in Virus Particles and Extracellular Vesicles". Viruses. 12 (9): 917. doi: 10.3390/v12090917 . PMC   7552034 . PMID   32825599.
  63. Su Q, Sena-Esteves M, Gao G (May 2019). "Purification of the Recombinant Adenovirus by Cesium Chloride Gradient Centrifugation". Cold Spring Harbor Protocols. 2019 (5): pdb.prot095547. doi:10.1101/pdb.prot095547. PMID   31043560. S2CID   143423942.
  64. Klepárník K, Boček P (March 2010). "Electrophoresis today and tomorrow: Helping biologists' dreams come true". BioEssays. 32 (3): 218–226. doi:10.1002/bies.200900152. PMID   20127703. S2CID   41587013.
  65. 1 2 Castro C, Marine R, Ramos E, Ng TF (22 June 2020). "The effect of variant interference on de novo assembly for viral deep sequencing". BMC Genomics. 21 (1): 421. doi: 10.1186/s12864-020-06801-w . PMC   7306937 . PMID   32571214.
  66. Cui J, Li F, Shi ZL (March 2019). "Origin and evolution of pathogenic coronaviruses". Nature Reviews. Microbiology. 17 (3): 181–192. doi:10.1038/s41579-018-0118-9. PMC   7097006 . PMID   30531947.
  67. Gorbalenya AE, Lauber C. Phylogeny of Viruses. Reference Module in Biomedical Sciences. 2017;B978-0-12-801238-3.95723-4. doi:10.1016/B978-0-12-801238-3.95723-4
  68. Koch L (July 2020). "A platform for RNA virus cloning". Nature Reviews. Genetics. 21 (7): 388. doi:10.1038/s41576-020-0246-8. PMC   7220607 . PMID   32404960.
  69. Thi Nhu Thao T, Labroussaa F, Ebert N, V'kovski P, Stalder H, Portmann J, Kelly J, Steiner S, Holwerda M, Kratzel A, Gultom M, Schmied K, Laloli L, Hüsser L, Wider M, Pfaender S, Hirt D, Cippà V, Crespo-Pomar S, Schröder S, Muth D, Niemeyer D, Corman VM, Müller MA, Drosten C, Dijkman R, Jores J, Thiel V (June 2020). "Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform". Nature. 582 (7813): 561–565. Bibcode:2020Natur.582..561T. doi: 10.1038/s41586-020-2294-9 . PMID   32365353. S2CID   213516085.
  70. Rosano GL, Morales ES, Ceccarelli EA (August 2019). "New tools for recombinant protein production in Escherichia coli: A 5-year update". Protein Science. 28 (8): 1412–1422. doi:10.1002/pro.3668. PMC   6635841 . PMID   31219641.
  71. Pennazio S (2006). "The origin of phage virology". Rivista di Biologia. 99 (1): 103–29. PMID   16791793.
  72. Harada LK, Silva EC, Campos WF, Del Fiol FS, Vila M, Dąbrowska K, Krylov VN, Balcão VM (2018). "Biotechnological applications of bacteriophages: State of the art". Microbiological Research. 212–213: 38–58. doi: 10.1016/j.micres.2018.04.007 . hdl: 1822/54758 . PMID   29853167. S2CID   46921731.
  73. 1 2 Stone E, Campbell K, Grant I, McAuliffe O (June 2019). "Understanding and Exploiting Phage-Host Interactions". Viruses. 11 (6): 567. doi: 10.3390/v11060567 . PMC   6630733 . PMID   31216787.
  74. Nagano K, Tsutsumi Y (January 2021). "Phage Display Technology as a Powerful Platform for Antibody Drug Discovery". Viruses. 13 (2): 178. doi: 10.3390/v13020178 . PMC   7912188 . PMID   33504115.
  75. Ibrahim B, McMahon DP, Hufsky F, Beer M, Deng L, Mercier PL, Palmarini M, Thiel V, Marz M (June 2018). "A new era of virus bioinformatics". Virus Research. 251: 86–90. doi:10.1016/j.virusres.2018.05.009. PMID   29751021. S2CID   21736957.
  76. Bamford D, Zuckerman MA (2021). Encyclopedia of virology. Amsterdam. ISBN   978-0-12-814516-6. OCLC   1240584737.{{cite book}}: CS1 maint: location missing publisher (link)
  77. McDonald SM, Nelson MI, Turner PE, Patton JT (July 2016). "Reassortment in segmented RNA viruses: mechanisms and outcomes". Nature Reviews. Microbiology. 14 (7): 448–60. doi:10.1038/nrmicro.2016.46. PMC   5119462 . PMID   27211789.
  78. Li J, Arévalo MT, Zeng M (2013). "Engineering influenza viral vectors". Bioengineered. 4 (1): 9–14. doi:10.4161/bioe.21950. PMC   3566024 . PMID   22922205.
  79. Lee CW (2014). "Reverse Genetics of Influenza Virus". Animal Influenza Virus. Methods in Molecular Biology. Vol. 1161. pp. 37–50. doi:10.1007/978-1-4939-0758-8_4. ISBN   978-1-4939-0757-1. PMID   24899418.
  80. Li Z, Zhong L, He J, Huang Y, Zhao Y (April 2021). "Development and application of reverse genetic technology for the influenza virus". Virus Genes. 57 (2): 151–163. doi:10.1007/s11262-020-01822-9. PMC   7851324 . PMID   33528730.
  81. Hull R, Rima B (November 2020). "Virus taxonomy and classification: naming of virus species". Archives of Virology. 165 (11): 2733–2736. doi: 10.1007/s00705-020-04748-7 . PMID   32740831. S2CID   220907379.
  82. Pellett PE, Mitra S, Holland TC (2014). "Basics of virology". Neurovirology. Handbook of Clinical Neurology. Vol. 123. pp. 45–66. doi:10.1016/B978-0-444-53488-0.00002-X. ISBN   9780444534880. PMC   7152233 . PMID   25015480.
  83. Simmonds P, Aiewsakun P (August 2018). "Virus classification - where do you draw the line?". Archives of Virology. 163 (8): 2037–2046. doi:10.1007/s00705-018-3938-z. PMC   6096723 . PMID   30039318.
  84. Lwoff A, Horne RW, Tournier P (June 1962). "[A virus system]". Comptes Rendus Hebdomadaires des Séances de l'Académie des Sciences (in French). 254: 4225–27. PMID   14467544.
  85. Lwoff A, Horne R, Tournier P (1962). "A system of viruses". Cold Spring Harbor Symposia on Quantitative Biology. 27: 51–55. doi:10.1101/sqb.1962.027.001.008. PMID   13931895.
  86. Fauquet CM, Fargette D (August 2005). "International Committee on Taxonomy of Viruses and the 3,142 unassigned species". Virology Journal. 2: 64. doi: 10.1186/1743-422X-2-64 . PMC   1208960 . PMID   16105179.
  87. International Committee on Taxonomy of Viruses Executive Committee (May 2020). "The New Scope of Virus Taxonomy: Partitioning the Virosphere Into 15 Hierarchical Ranks". Nat Microbiol. 5 (5): 668–674. doi:10.1038/s41564-020-0709-x. PMC   7186216 . PMID   32341570.
  88. Khan MK, Alam MM (July 2021). "Norovirus Gastroenteritis Outbreaks, Genomic Diversity and Evolution: An Overview". Mymensingh Medical Journal. 30 (3): 863–873. PMID   34226482.
  89. Eberle J, Gürtler L (2012). "HIV types, groups, subtypes and recombinant forms: errors in replication, selection pressure and quasispecies". Intervirology. 55 (2): 79–83. doi: 10.1159/000331993 . PMID   22286874. S2CID   5642060.
  90. Delwart EL (2007). "Viral metagenomics". Reviews in Medical Virology. 17 (2): 115–31. doi:10.1002/rmv.532. PMC   7169062 . PMID   17295196.
  91. 1 2 "Virus Taxonomy: 2021 Release". International Committee on Taxonomy of Viruses. Retrieved 4 April 2022.
  92. Koonin EV, Krupovic M, Agol VI (August 2021). "The Baltimore Classification of Viruses 50 Years Later: How Does It Stand in the Light of Virus Evolution?" (PDF). Microbiology and Molecular Biology Reviews. 85 (3): e0005321. doi:10.1128/MMBR.00053-21. PMC   8483701 . PMID   34259570. S2CID   235821748.


  • Collier L, Balows A, Sussman M (1998). Mahy B, Collier LA (eds.). Topley and Wilson's Microbiology and Microbial Infections. Virology. Vol. 1 (Ninth ed.). ISBN   0-340-66316-2.
  • Dimmock NJ, Easton AJ, Leppard K (2007). Introduction to Modern Virology (Sixth ed.). Blackwell Publishing. ISBN   978-1-4051-3645-7.
  • Shors T (2017). Understanding Viruses. Jones and Bartlett Publishers. ISBN   978-1-284-02592-7.